Joint Formulary & PAD

Budesonide (Budelin Novolizer) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :
Important

Not for initiation in new patients.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Budesonide (Budelin Novolizer)
Indication :
Asthma
Group Name :
ICS
Keywords :
ICS, inhaled corticosteroids, respiratory, asthmatics
Brand Names Include :
Budelin Novolizer
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Budesonide (Budelin Novolizer) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (1)

This product or device has not been included within the locally agreed list of preferred treatment options for Asthma. Please see Asthma Guidelines below.

There is no expectation for existing, stable patients to change drug or device unless this is agreed as a clinically appropriate course of action.

Prescribe inhaler devices by BRAND to ensure consistency and avoid confusion